PTC Therapeutics, Inc.

  • Resolved

Investigation
05/12/2022

Resolution
06/08/2022

Investigation

  • Continous Holding
    January 1, 2021 to August 15, 2022
  • Proposed Claim
    Breach of Fiduciary Duty

This is a confidential investigation of whether certain directors & officers of PTC Therapeutics, Inc. (PTCT) breached their fiduciary duties to PTC and its shareholders.

PTC investors and shareholders are encouraged to contact the law firm below for additional information.

Main Event

Annual Meeting

04/28/2022

SEC Filing

SpringWorks Therapeutics, Inc. files its DEF 14A proxy materials with the SEC for its 2022 annual shareholder meeting.

See more on Factual Timeline

Resolution

We have marked this investigation as closed.

Why was the case resolved?

The stockholders annual meeting took place.
On 06/08/2022 the company issued the following statement:

[stockdio-historical-chart symbol=”PTCT” stockExchange=”NYSENasdaq” width=”500″ height=”330″ motif=”blinds” palette=”humanity” includeVolume=false]

Factual Timeline

More

More Cases & Investigations
Privacy Policy
© Copyright 2026 Brios Services LLC
Terms & Conditions